Chemistry: natural resins or derivatives; peptides or proteins; – Proteins – i.e. – more than 100 amino acid residues
Patent
1995-06-02
1998-11-17
Feisee, Lila
Chemistry: natural resins or derivatives; peptides or proteins;
Proteins, i.e., more than 100 amino acid residues
530412, 435 691, C12P 1206, C07K 1400, A23J 100
Patent
active
058378154
ABSTRACT:
The present invention features a method for treatment of an organism having a disease or condition characterized by an abnormality in a signal transduction pathway, wherein the signal transduction pathway include a PYK2 protein. The invention also features methods for diagnosing such diseases and for screening for agents that will be useful in treating such diseases. The invention also features purified and/or isolated nucleic acid encoding a PYK2 protein.
REFERENCES:
Ezoc, K et al. Onougene 9(3): 935-8, 1994.
Johnson, JD. PMAS, USA, 90 (12): 5677-81, 1993.
Kubo et al. Nature, 323: 411-416, 1986.
Whitney et al (DNA Cell Biol., 1993, 12: 823-830).
Sambrook et al (Molecular Cloning, A Lab Manual, 1989.
Cold Spring Harbor, Cold Sring Harbor Press pp. 9.5-9.51.
Aaronson, S., "Growth Factors and Cancer," Science 254:1146-1153 (1991).
Adelman et al., "In Vitro Deletional Mutagenesis for Bacterial Production of the 20,000-Dalton Form of Human Pituitary Growth Hormone," DNA 2(3):183-193 (1983).
Allen et al., "Modulation of CD4 by suramin" Clin. Exp. Immunol. 91:141-146 (1991).
Anafi et al., "Tyrphostin-Induced Inhibition of p120.sup.bcr-abl Tyrosine Kinase Activity Induces K562 to Differentiate," Blood 82:3524-3529 (1993).
Baker et al., "Induction of acetylcholine receptor clustering by native polystyrene beads" Journal of Cell Science 102:543-555 (1992).
Barker et al., "In vitro activity of non-glutamate containing quinazoline-based thymidylate synthase inhibitors" Proceedings of the American Association for Cancer Research 32:327 (#1939) (1991).
Benoist and Chambon, "In vivo sequence requirements of the SV40 early promoter region," Nature 290:304-310 (1981).
Bertino, "Toward Improved Selectivity in Cancer Chemotherapy: The Richard and Hinda Rosenthal Foundation Award Lecture" Cancer Research 39:293-304 (Feb. 1979).
Bilder et al., "Tyrphostins inhibit PDGF-induced DNA synthesis and associated early events in smooth muscle cells," Am. I. Physiol. 260 (Cell Physiol.29):C721-C730 (1991).
Bird et al., "Single-Chain Antigen-Binding Proteins," Science 242:423-426 (1988).
Bitter et al., "Expression and Secretion Vectors for Yeast," Methods in Enzym. 153:516-544 (1987).
Brinster et al., "Factors Affecting the Efficiency of Introducing Foreign DNA into Mice by Microinjecting Eggs," Proc. Natl. Acad. Sci. USA 82:4438 (1985).
Brown and Birnbaumer, "Ionic Channels and Their Regulation by G Protein Subunits," Ann. Rev. Physiol. 52:197-213 (1990).
Brunton et al., "Anti-tumour activity of novel tryphostins in breast cancer cells." Proceedings of the American Association for Cancer Research 33:558 (1992) (#3335).
Bryckaert et al., "Inhibition of Platelet-Derived Growth Factor-Induced Mitogenesis and Tyrosirie Kinase Activity in Cultured Bone Marrow Fibroblasts by Tyrphostins," Exp. Cell Research 199:255-261 (1992).
Burke Jr. et al., Bicyclic Compounds as Ring-Constrained Inhibitors of Protein-Tyrosine Kinase p56.sup.Lck 1 Journal of Medicinal Chemistry 36(4):425-432 (1993).
Burke et al., "Arylamides of Hydroxylated Isoquinolines as Protein-Tyrosine Kinase Inhibitors" Bioorganic & Medical Chemistry Letters 2(12):1771-1774 (1992).
Cantrell, D., "G proteins in lymphocyte signalling," Current in Immunology 6:380-384 (1994).
Carmeliet, "Ion channel agonists: expectations for therapy," Eur. Heart. J. 12:30-37 (1991).
Chen and Okayama, "High-Efficiency Transformation of Mammalian Cells by Plasmid DNA," Mol. and Cell. Biol. 7(8):2745-2752 (1987).
Chowdhury et al., "Long-term Improvement of Hypercholesterolemia After Ex Vivo Gene Therapy in LDLR-Deficient Rabbits," Science 254:1082 (1991).
Cobb et al., "Stable Association of pp60.sup.src and pp59.sup.fyn with the Focal Adhesion-Associated Protein Tyrosine Kinase, pp 125.sup.FAK," Mol. and Cell. Biol. 14:147-155 (1994).
Colbere-Garapin et al., "A New Dominant Hybrid Selective Marker for Higher Eukaryotic Cells," J. Mol. Biol. 150:1-14 (1981).
Cole et al., "The EBV-Hybridoma Technique and its Application to Human Lung Cancer," pp. 77-96 in Monoclonal Antibodies and Cancer Therapy eds. Reisfeld and Sell, Alan R. Liss, Inc., New York (1985).
Creighton, T., Proteins: Structures and Molecular Principles pp. 79-86, W.H. Freeman and Co., New York, (1983).
Cristiano et al., "Hepatic Gene Therapy: Adenovirus Enhancement of Receptor-Mediated Gene Delivery and Expression in Primary Hepatocytes," Proc. Natl. Acad. Sci. USA 90:2122-2126 (1993).
Curiel et al., "Adenovirus Enhancement, of Transferrin-polylysine-mediated Gene Delivery," Proc. Natl. Acad. Sci. USA 88:8850 (1991).
Curiel et al., "Adenovirus Enhancement of Transferrin-Polylysine-Mediated Gene Delivery," Proc. Nat. Acad. Sci. USA 88:8850-8854 (1991).
Curtin et al., "Inhibition of the growth of human hepatocellular carcinoma in vitro and in athymic mice by a quinazoline inhibitor of thymidylate synthase, CB3717" Br. I. Cancer 53:361-368 (1986).
Dolle et al., "5,7-Dimethoxy-3-(4-pyridinyl)quinoline is a Potent and Selective Inhibitor of Human Vascular.beta.-Type Platelet-Derived Growth Factor Receptor Tyrosine Kinase" J. Med. Chem. 37:2627-2629 (1994).
Dolphin, A., "G Protein Modulation of calcium Currents in Neurons," Ann. Rev. Physiol. 52:243-55 (1990).
Domchek et al., "Inhibition of SH2 Domain/Phosphoprotein Association by a Nonhydrolyzable Phosphonopeptide," Biochemistry 31:9865-9870 (1992).
Dong et al., "Protein Tyrosine Kinase Inhibitors Decrease Induction of Nitric Oxide Synthase Activity in Lipopolysaccharide-Responsive and Lipopolysaccharide-Nonresponsibe Murine Macrophages" The Journal of Immunology 151(5):2717-2724 (Sep. 1993).
Dong et al., "Activation of tumoricidal properties in macrophages by lipopolysaccharide requires protein-tyrosine kinase activity" Journal of Leukocyte Biology 53:53-60 (Jan. 1993).
Fanti et al., "Distinct Phosphotyrosines on a Growth Factor Receptor Bind to Specific Molecules That Mediate Different Signaling Pathways," Cell 69:413-423 (1992).
Felder et al., "SH2 Domains Exhibit High-Affinity Binding to Tyrosine-Phosphorylated Peptides Yet Also Exhibit Rapid Dissociation and Exchange," Mol. and Cell. Biol. 13(3):1449-1455. (1993).
Felgner and Ringold, "Cationic liposome-mediated transfection," Nature 337:387-388 (1989).
Felgner et al., "Lipofection: A Highly Efficient, Lipid-mediated DNA-transfection Procedure," Proc. Natl. Acad. Sci. USA 84:7413 (1987).
Fernandes et al., "Biochemical and Antitumor Effects of 5,8-Dideazaisopteroylglutamate, a Unique Quinazoline Inhibitor of Thymidylate Synthase" Cancer Research 43:1117-1123 (1983).
Ferrari et al., "An in Vivo Model of Somatic Cell Gene Therapy for Human Severl Combined Immunodeficiency," Science 251:1363-1366 (1991).
Ferris et al., "Synthesis of Zuinazoline Nucleosides from Ribose and Anthranilonitrile. Application of Phase-Transfer Catalysis in Nucleoside Synthesis," J. Org. Chem. 44(2):173-178 (1979).
Fingl and Woodbury, Chapter 1, pp. 1-46 in The Pharmacological Basis of Therapeutics (5th edition),eds. Goodman et al., MacMillan Publishing Co., Inc., New York (1975).
Fischer and Schonbrunn, "Bombesin Receptor is Coupled to a Guanine Cholera Toxins," J. Biol. Chem. 263:2808-2816 (1988).
Fischer et al., "Protein Tyrosine Phosphatases: A Diverse Family of Intracellular and Transmembrane Enzymes," Science 253:401-406 (1991).
Frucht et al., "Characterization of Functional Receptors for Gastrointestinal Hormones on Human Colon Cancer Cells," Cancer Research 52:1114-1122 (1992).
Fry et al., "A Specific Inhibitor of the Epidermal Growth Factor Receptor Tyrosine Kinase" Science 465:1093-1095 (Aug. 1994).
Fry et al., "New insights into protein-tyrosine kinase receptor signaling complexes," Protein Science 2:1785-1797 (1993).
Gazit et al., "Tyrphostins. 1. Synthesis and Biological Activity of Protein Tyrosine Kinase Inhibitors," J. Med. Chem. 32:2344-2352 (1989).
Gazit et al., "Tyrphostins. 2. Heterocyclic and .alpha.-Substituted Benzylidenemalononitrile Tyrphostins as Potent Inhibitors of EGF Receptor and ErbB2
eu Tyrosine Kinases," J. Med. Chem. 34:1896-1907 (1991).
Gazit et al., "Tyrphostins. 3. Structure-Activity Relationship Studie
Lev Sima
Schlessinger Joseph
Feisee Lila
Sugen Inc.
Ungar Susan
LandOfFree
PYK2 related polypeptide products does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with PYK2 related polypeptide products, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and PYK2 related polypeptide products will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-885425